Commentary on the Brugada ECG pattern a marker of channelopathy, structural heart disease, or neither? Toward a unifying mechanism of the Brugada syndrome

Circulation: Arrhythmia and Electrophysiology

Volumn 3, Issue 3, 2010, Pages 280-282

  Brugada, Pedro ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Arrhythmia; Brugada syndrome; Electrocardiography; Sodium

Indexed keywords

BRUGADA SYNDROME; CARDIOMYOPATHY; CHAGAS DISEASE; CHANNELOPATHY; CLINICAL FEATURE; ELECTROCARDIOGRAM; GENE MUTATION; GENETIC HETEROGENEITY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTENSION; HYPERTHYROIDISM; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH; ANIMAL; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; PREDICTION AND FORECASTING; RISK FACTOR;

ION CHANNEL;

ANIMALS; BRUGADA SYNDROME; ELECTROCARDIOGRAM PATTERN; GENETIC PREDISPOSITION TO DISEASE; HEART DISEASES; HUMANS; ION CHANNELS; MUTATION; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 77954665422     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.110.957258     Document Type: Note

References (11)

1. Hoogendijk MG, Opthof T, Postema PG, Wilde AA, de Bakker JM, Coronel R. The Brugada ECG Pattern: A Marker of Channelopathy, Structural Heart Disease or Neither? Towards a Unifying Mechanism of the Brugada Syndrome. Circ Arrhythm Electrophysiol. 2010;3:283-290.
2. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20: 1391-1396.
3. Dumaine R, Towbin JA, Brugada P, Vatta M, Nesterenko DV, Nesterenko VV, Brugada J, Brugada R, Antzelevitch C. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res. 1999;85:803-809.
4. Brugada syndrome: the official site of the Ramon Brugada Senior Foundation. http://www.brugada.org.
5. Introduction to BrugadaDrugs.org. http://www.brugadadrugs.org.
6. Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, Babuty D, Sacher F, Giustetto C, Schulze-Bahr E, Borggrefe M, Haissaguerre M, Mabo P, Le Marec H, Wolpert C, Wilde AA. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry. Circulation. 2010;121:635-643.
7. Benito B, Campuzano OF, Ishac R, Iglesias A, Junttila J, Michaud J, Brugada J, Brugada P, Brugada R. Role of genetic testing in risk stratification of Brugada syndrome. Available at: http://www.abstractsonline.com. Heart Rhythm Society 2009.
8. Chiale PA, Przybylski J, Lainõ RA, Halpern MS, Sánchez RA, Gabrieli A, Elizari MV, Rosenbaum MB. Electrocardiographic changes evoked by ajmaline in chronic Chagas' disease with manifest myocarditis. Am J Cardiol. 1982;49:14-20.
9. Kapplinger JD, Tester DJ, Alders M, Benito B, Berthet M, Brugada J, Brugada P, Fressart V, Guerchicoff A, Harris-Kerr C, Kamakura S, Kyndt F, Koopmann TT, Miyamoto Y, Pfeiffer R, Pollevick GD, Probst V, Zumhagen S, Vatta M, Towbin JA, Shimizu W, Schulze-Bahr E, Antzelevitch C, Salisbury BA, Guicheney P, Wilde AA, Brugada R, Schott JJ, Ackerman MJ. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm. 2010;7:33-46.
10. Belhassen B, Viskin S, Fish R, Glick A, Setbon I, Eldar M. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol. 1999;10:1301-1312.
11. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O'Brien RE, Schulze-Bahr E, Keating MT, Towbin JA, Wang Q. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392:293-296.